摘要
Acetaminophen (APAP) overdose is a leading cause of acute hepatic failure and liver transplantation, while the existing treatments are poorly effective. Therefore, it is necessary to develop effective therapeutic drugs for APAP-induced hepatotoxicity. Farnesoid X receptor (FXR) is a potential target for the treatment of liver disease, and the activation of FXR protects mice against APAP-induced hepatotoxicity. Compound 5, a glycine-conjugated derivative of FXR agonist 4, was designed to extend the chemical space of existing FXR agonists. Molecular modeling study indicated that compound 5 formed hydrogen bond network with key residues of FXR. Moreover, compound 5 (10 mg/kg) revealed better protective effects against APAP-induced hepatotoxicity than parent compound 4 (30 mg/kg). Further mechanical research indicated that compound 5 regulated the expressions of genes related to FXR and oxidative stress. These findings suggest that compound 5 is a promising FXR agonist suitable for further research, and it is the first time to verify that the glycine-conjugated derivative five exerted better protective effects than its parent compound.
学科与关键词
- Discovery of LH10, a novel fexaramine-based FXR agonist for the treatment of liver diseaseHuang, Wanqiu; Cao, Zhijun; Wang, Wenxin; Yang, Zhongcheng; Jiao, Shixuan; Chen, Ya; Chen, Siliang; Zhang, Luyong*; Li, Zheng*Bioorganic Chemistry, 2024, 143: 107071.
- Hepatic SIRT6 Modulates Transcriptional Activities of FXR to Alleviate Acetaminophen-induced HepatotoxicityLiu, Changhui; Pan, Zhisen; Wu, Zhouli; Tang, Kaijia; Zhong, Yadi; Chen, Yingjian; Xiao, Xiaoxia; Guo, Jingyi; Duan, Siwei; Cui, Tianqi; Zhong, Guangcheng; Yang, Zifeng*; Zhong, Chong*; Lin, Sheng*; Gao, Yong*Cellular and Molecular Gastroenterology and Hepatology, 2022, 14(2): 271-293.被引 12
- Design, synthesis, and biological studies of novel sulfonamide derivatives as farnesoid X receptor agonistsWang, Wenxin; Cao, Zhijun; Yang, Zhongcheng; Chen, Ya; Yao, Huixin; Zhou, Danting; Ou, Peixin; Huang, Wanqiu; Jiao, Shixuan; Chen, Siliang; Chen, Lianru; Liu, Yuxia; Mao, Jianming; Xie, Jiayi; Xiang, Ruojing; Yang, Yuanqian; Chen, Yisi; Yang, Yonghong; Tan, Liyun; Tang, Haolong; Zhang, Luyong*; Li, Zheng*European Journal of Medicinal Chemistry, 2023, 258: 115614.
